Replies to post #153585 on Bioelectronics Corp (BIEL)

[JustGoDeep]

Biel Lining up Billion Dollar Companies To Sell Actipatches

When Biel Does $2.5-Million in Sales a Quarter

two pennies to a nickel or more are in play.

With all that is in play right now and coming it will be happening soon enough.

B. Braun --------------------------Multi Bilion Dollar Company
Mundipharma -------------------Multi Billion Dollar Company
Performance Health ----------Part of about a Billion Dollar Company
NHS U.K. Government -------Multi Billion Dollar Healthcare System
Rest of the World --------------Multiples of Billions
Dr. Scholls and Bayer--------Multi Billion Dollar Company
Anda, Inc and Teva------------Multi Billion Dollar Company
Evomed---------------------------
Avanfarma-----------------------------
Selected CVS Stores------------------------

Oh Yeah and

AMERICA------------------------HONEYPOT

Keep an eye on Mundipharma. Sleeper of the bunch. Expecting GREAT things.

By sleeper I mean people don't see it coming. My Opinion, it is coming Fast!!

We can ALL see B. Braun Coming!!

[JustGoDeep]

YUP!! Very SCARY MONSTER!! PROOF!!

CLUE: In a Year or Less B. Braun

will have the following impact.

Want to GUESS what this ALONE will do to Share Price!!!

B. Braun is a Big Deal

----

B.Braun 80,000 Boxes of Actipatches a year for each Surgery X Box of 6

at about $78.33 a box = $6,266,400

NHS pays for the Box of Actipatches post surgery.

1 Actipatch at $19.67 each X 80,000 Surgeries a year = $1,573,600

$6,266,400 + $1,573,600 = $7,840,000 for the U.K.

Add Germany at about 100,000 surgeries a year X Box of 6 at $78.33 = $7,833,000

100,000 X 1 Actipatch per Surgery at $19.67 each = $1,967,000

$7,883,000 + $1,967,000 = $9,800,000 for Germany.

$7,840,000 for the U.K. + $9,800,000 for Germany = $17,640,000

Add to that 1-12 Pre Surgery Actipatches at $19.67 X about 180,000

and you begin to see what is going on with Biel!!

Just a matter of time now.

Now how much of that does Biel get and what is the Profit amount?

I have a good estimate, do you?

Clue: Profitable and Well North of Two Pennies.

Now add in all the other revenues sources such as NHS, other Spain, World Sales, Dr. Scholls,

Mundipharma and Evomed.

ALL HAPPENING!!

FREAKY MONSTER!!

BUY HOLD RETIRE!!

[Gramps]

And yet, still seems to hold the interest of so many investors... Must be they believe FDA clearance is imminent. Must be they believe that BIEL will be one of the awardees by the FDA Challenge program, must be they believe that the future retail markets are ripe for BIEL's products. Scary potential, isn't it....

Ooooo monster, scary!

Scary financials last quarter.

Scary that this management team is feckless, and just can’t seem to do the right thing.

Scary that we haven’t received fda approval, especially after they met with the company prior to the submission.

Not really a monster, more of a gross bug.